Immucor Gti Diagnostics Inc Waukesha, WI - 53186

Immucor Gti Diagnostics Inc is categorized under In Vitro Diagnostics in Waukesha, WI and active since 2010.

Immucor Gti Diagnostics Inc was established in 2010, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a In Vitro Diagnostics business, which does work in the B2B market, and is classified as a In Vitro Diagnostics, under code number 325413 by the NAICS.

If you are seeking more information, feel free to contact Jim Tidey at the company’s single location by writing to 20925 Crossroads Circle, Waukesha, Wisconsin WI 53186 or by phoning (262) 754-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Immucor Gti Diagnostics Inc
Contact Person: Jim Tidey
Address: 20925 Crossroads Circle, Waukesha, Wisconsin 53186
Phone Number: (262) 754-1000
Website Address: gen-probe.com
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: In Vitro Diagnostics
SIC Code: 2835
NAICS Code: 325413
Share This Business:

Immucor Gti Diagnostics Inc was started in 2010 to provide professional In Vitro Diagnostics under the SIC code 2835 and NAICS code 325413. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Jim Tidey for inquiries that concern Immucor Gti Diagnostics Inc by calling the company number (262) 754-1000, as your correspondence is most welcome. Additionally, the physical location of the single location of Immucor Gti Diagnostics Inc can be found at the coordinates as well as the street address 20925 Crossroads Circle in Waukesha, Wisconsin 53186.

For its online presence, you may visit Immucor Gti Diagnostics Inc’s website at gen-probe.com and engage with its social media outlets through on Twitter and on Facebook.